-
Loading metrics
A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations
- Neal Van Hoeven,
- Sharvari Waghmare Joshi,
- Ghislain Ismael Nana,
- Angela Bosco-Lauth,
- Christopher Fox,
- Richard A. Bowen,
- David E. Clements,
- Timothy Martyak,
- D. Elliot Parks,
- Susan Baldwin
x
- Published: February 22, 2016
- https://doi.org/10.1371/journal.pone.0149610